CN1203883C - Capsule for softening liver - Google Patents
Capsule for softening liver Download PDFInfo
- Publication number
- CN1203883C CN1203883C CNB031115713A CN03111571A CN1203883C CN 1203883 C CN1203883 C CN 1203883C CN B031115713 A CNB031115713 A CN B031115713A CN 03111571 A CN03111571 A CN 03111571A CN 1203883 C CN1203883 C CN 1203883C
- Authority
- CN
- China
- Prior art keywords
- liver
- softening
- capsule
- medicine
- gram
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The present invention discloses a medicine for treating liver cirrhosis, namely a liver-softening capsule whose main components comprise saffron, zedoray rhizome, olibanum, rehmannia root, pangolin scales, oyster shell, gecko, gentian root, red sage root, turtle shell, myrrh, notoginseng, musk, cow-bezoar, etc. The medicines are mixed and ground into fine powder, and the fine powder is admitted by encapsulating. The liver-softening capsule has the advantages of scientific and reasonable preparation process and no toxic or side effect, and ready prepared medicines are free of abnormal smells. Proved by clinical practice, the liver-softening capsule has a therapeutic effect of softening the liver on liver cirrhosis, and has a cure rate of 90% and an obvious cure rate of 96%.
Description
One, technical field
The utility model relates to a kind of medicine for the treatment of liver cirrhosis.
Two, background technology
Liver cirrhosis is a kind of chronic disease that influences the human body whole body, is the late stage of hepatic disease.Pathological characteristic is hepatocellular degeneration, necrosis, cellular tissue parenchyma's hypertrophy, and the disorder of liver normal configuration makes a kind of slow inflammation of liver distortion, hardening.In recent years, along with the sickness rate increase of posthepatitic cirrhosis, treated this disease and classified difficult miscellaneous diseases clinically as.Before the present invention proposed, the used medicine of treatment liver cirrhosis had the horse network for fat, interferon, colchicine etc., and this medicine has toxic and side effects through clinical practice, influential stomach function, loss of appetite is felt sick, abdominal distention diarrhoea, headache, drowsiness, the transaminase raises, untoward reaction such as numb hand and foot, and cure rate is low.
Three, summary of the invention
In order to solve the deficiencies in the prior art, the invention provides a kind of having no side effect, and the medicine of the high treatment liver cirrhosis of cure rate.
The technical scheme that solves its technical problem employing is: get Stigma Croci, Rhizoma Curcumae, Olibanum, the Radix Rehmanniae, Squama Manis, Concha Ostreae, Gekko Swinhonis, Radix Gentianae, each 50 gram of Radix Salviae Miltiorrhizae; Carapax Trionycis, each 100 gram of Myrrha, Radix Notoginseng 35 grams, Moschus 5 grams; Calculus Bovis 0.2 gram, it is encapsulated oral to be ground into fine flour after the mixing.
The invention has the beneficial effects as follows: the medicine of this treatment liver cirrhosis through clinical take to observe have activating blood circulation to dissipate blood stasis, soft liver eliminating stagnation, heat clearing away YIN nourishing, detoxifcation, improve the liver blood circulatory function, can prevent that hepatic necrosis, tuberosity from forming, absorb the hepatocyte structural fibersization, softening hepatic tissue has good curative effect, cure rate height to liver cirrhosis, cure rate reaches 90%, and obvious effective rate reaches 96%; The natural plants that consists of owing to medicine has no side effect, and cheap, is suitable for the crowd of various incomes.
The liver cirrhosis clinical manifestation can be divided into the compensatory phase and lose the compensatory phase, and the pathogenesis of compensatory phase of liver cirrhosis is a knot and causing in the qi stagnation blood stasis, and damp and hot, cold-evil's expectorant is turbid to be to facilitate the qi stagnation blood stasis indirect factor; That cirrhosis patients in decompensation is mainly is damp and hot, the deficiency of YIN, yang deficiency, the three dirty imbalances of liver spleen kidney, and water retention is still arranged except that stagnation of QI blood stasis.The Radix Gentianae that the present invention forms, Moschus, Calculus Bovis, Gekko Swinhonis energy blood circulation promoting and dispersing pathogen accumulation, heat-clearing and toxic substances removing, eliminating pathogen in the liver gallbladder excess-fire, the refreshment of having one's ideas straightened out, hepatoprotective has protection and repair to the liver cell that damages.Squama Manis, Concha Ostreae, Rhizoma Curcumae energy yin fluid astringing, activating blood circulation to dissipate blood stasis, hemostasis, soft liver.Olibanum, Myrrha can break congestion, removing food stagnancy reducing swelling and alleviating pain by shape gas.The Radix Rehmanniae, Radix Salviae Miltiorrhizae energy clearing away heat and cooling blood, YIN nourishing and the production of body fluid promoting, the silt of invigorating blood circulation, the mind calming pain relieving all has good effect to hepatosplenomegaly.Because the present invention carries out reasonable compatibility with above-mentioned Chinese medicine composition, through clinical 105 routine cases are treated, 93 examples of fully recovering, produce effects 8 examples, effective 4 examples, cure rate reaches 90%.Patient Jin Tao, man, 44 years old, the cadre of water conservancy bureau.The main malaise of stating, liver press thorn to educate, and night, difficulty was fallen asleep, with feeling sick, and vomiting, appetite is poor, and secret when half congealed during stool, the yellowish or reddish urine amount is little.Through the indagation of the big Affiliated Hospital of Chinese medical courses in general, be diagnosed as liver cirrhosis late period.Took medicine of the present invention 30 days, liver is pressed pain relief, and can fall asleep night, and abdominal wall varicosis disappears, and appetite increases slightly, can out-of-bed activity.Appetite is cumulative after taking medicine 6 months, and muscle is plump, and spirit is healthy and vigorous, can participate in sports activites.After 1 year, face is plump, and gun-ho can be walked by bike and at a distance.B ultrasonic is rechecked, and liver spleen waveform is normal, and the liver spleen is little, no ascites.So far be almost recovered.
Claims (1)
1, a kind of medicine for the treatment of liver cirrhosis is characterized in that: Stigma Croci, Rhizoma Curcumae, Olibanum, the Radix Rehmanniae, Squama Manis, Concha Ostreae, Gekko Swinhonis, Radix Gentianae, each 50 gram of Radix Salviae Miltiorrhizae, Carapax Trionycis, each 100 gram of Myrrha; Radix Notoginseng 35 grams; Moschus 5 gram, Calculus Bovis 0.2 gram, it is encapsulated to be ground into fine flour after the mixing.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB031115713A CN1203883C (en) | 2003-04-29 | 2003-04-29 | Capsule for softening liver |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB031115713A CN1203883C (en) | 2003-04-29 | 2003-04-29 | Capsule for softening liver |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1480174A CN1480174A (en) | 2004-03-10 |
| CN1203883C true CN1203883C (en) | 2005-06-01 |
Family
ID=34152383
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB031115713A Expired - Fee Related CN1203883C (en) | 2003-04-29 | 2003-04-29 | Capsule for softening liver |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1203883C (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101549034B (en) * | 2009-05-07 | 2011-04-13 | 崔霞 | Medicine for treating liver cirrhosis |
| CN102920860B (en) * | 2012-11-29 | 2015-03-18 | 中央民族大学 | National medicinal composition for treating liver diseases |
| CN103142931B (en) * | 2013-03-06 | 2014-06-04 | 北京亚东生物制药有限公司 | Traditional Chinese medicine composite for treating liver cancer and preparation method thereof |
-
2003
- 2003-04-29 CN CNB031115713A patent/CN1203883C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1480174A (en) | 2004-03-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103156972B (en) | Traditional Chinese medicine combination for treating fracture, hairline fracture and traumatic injury | |
| CN102895603B (en) | Chinese herbal medicine for treating gastro-intestinal diseases | |
| CN102526616B (en) | Chinese medicinal herb pills for treating cholecystitis and gallstone | |
| CN102091252B (en) | Traditional Chinese medicine composition for treating periodontitis | |
| CN101264287A (en) | Orally-administered Chinese medicine for treating acne and preparation thereof | |
| CN103550695B (en) | Medicament for treating breast cancer | |
| CN1868531A (en) | Traditional Chinese medicine composition for treating hepatolith | |
| CN101695555B (en) | Medicament composition for treating prostatitis and prostatomegaly and preparation method thereof | |
| CN103735927B (en) | A kind of Chinese medicine composition for the treatment of acute stage of gout and preparation method thereof | |
| CN104922281A (en) | Traditional Chinese medicine composition of patch-type ointment for treating slow-transit constipation and preparation method thereof | |
| CN1203883C (en) | Capsule for softening liver | |
| CN102755515B (en) | Traditional Chinese medicine decoction for treating hyperplasia of mammary glands | |
| CN102228648B (en) | Chinese medicinal composition for treating icterohepatitis | |
| CN102145143B (en) | Pharmaceutical composition for treatment of gastritis and preparation method of pharmaceutical composition | |
| CN104491775A (en) | Tradtional Chinese medicament for treating post cerebral hemorrhage depressions | |
| CN101757444A (en) | Orally administrated medicine for Chinese traditional treatment of thyroid nodule | |
| CN100579544C (en) | Chinese medicament preparation for treating cholecystitis and gall-stone as well as preparation method thereof | |
| CN102247486B (en) | Bone health care marrow filling capsule | |
| CN104056172A (en) | Traditional Chinese medicine composition for treating stomach diseases and preparation method of traditional Chinese medicine composition capsules | |
| CN104825598A (en) | External-use plaster for treating rheumatic bone pain and preparation method thereof | |
| CN100534473C (en) | Orally-administered traditional Chinese medicine composition for treating toothache | |
| CN101554469A (en) | Traditional Chinese medicine formula for curing gallstones during period of onset | |
| CN101041013A (en) | Chinese traditional medicine compound took orally for treating anal fissure | |
| CN105288511A (en) | Traditional Chinese medicine composition for treating scapulohumeral periarthritis and preparation method thereof | |
| CN103100050B (en) | Chinese medicament for treating angina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |